Takeda's Shareholders Agree to $58 Billion Shire Deal Despite Debt Fears - Fortune

Takeda will issue $35 billion in new stock. The long-running saga that is Takeda’s proposed takeover of Adderall maker Shire is about to enter a new chapter, with the Japanese firm’s shareholders approving the deal. On Wednesday.....»»

The boss of Japan's Takeda Pharmaceutical said on Monday he was confident of securing investor backing for its $62 billion acquisition of London-listed Shire , despite some shareholders' fears about the resulting debt burden......»»

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt......»»

Shire said it is willing to recommend that shareholders accept Takeda Pharmaceutical’s last-ditch $64 billion takeover bid and extended the deadline for a possible deal......»»

LONDON/NEW YORK (Reuters) - London-listed drugmaker Shire Plc said it was willing to recommend a deal with Takeda Pharmaceutical Co to its shareholders, after the Japanese company sweetened its acquisition offer to 46 billion pounds ($64 billion)......»»

Takeda Pharmaceutical hopes that their $62 billion deal to purchase Shire will make them a global bio-pharmaceutical leader. But as Silvia Antonioli reports, it comes with a heavy debt burden......»»

TOKYO (Reuters) - A group of Takeda Pharmaceutical Co Ltd shareholders is building support to block the $62 billion acquisition of London-listed Shire Plc at an extraordinary general meeting, a leading member of the group told Reuters on Monday......»»

TOKYO (Reuters) - A group of Takeda Pharmaceutical Co Ltd shareholders is trying to build support to block the $62 billion acquisition of London-listed Shire Plc at an extraordinary general meeting, a leading member of the group told Reuters on Monday......»»

A group of Takeda Pharmaceutical shareholders is trying to build support to block the $62 billion acquisition of London-listed Shire at an extraordinary general meeting, a leading member of the group told Reuters on Monday......»»

Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion purchase of the London-listed drugmaker, as it looks to cut the debt raised to fund the deal, Bloomberg reported on Thursday......»»

European Union antitrust regulators have conditionally approved Takeda Pharmaceutical Co. Ltd.'s $62 billion bid to acquire Shire plc, a deal that will likely create the largest life sciences employer in Massachusetts. The European Commission sai.....»»

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , a Takeda spokesman said, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt......»»

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt......»»

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt. Julian Satterthwaite reports......»»

Takeda Pharmaceutical has won shareholder approval for its $59 billion takeover of London-listed Shire , creating a global powerhouse that has a stronger drugs pipeline but is also saddled with massive debt......»»

The British businesses of Liberty Global Plc and Telefonica SA will merge to create a major new player in UK mobile and broadband communications in a deal valued at around 31 billion pounds ($38 billion) including debt......»»

PDC Energy Inc. and SRC Energy Inc. said Monday they have entered an agreement for PDC to acquire SRC in an all-stock deal valued at about $1.7 billion, including SRC's debt of about $685 million. SRC shareholders will receive 0.158 PDC shares for .....»»

Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in western Europe as it seeks to trim its debt following the $59 billion purchase of Shire, sources close to the matter told Reuters......»»

Takeda Pharmaceutical Co Ltd agreed to sell its dry eye drug to Swiss drugmaker Novartis AG for $3.4 billion and potential milestone payments of up to $1.9 billion, in the first divestment since its takeover of Britain's Shire......»»

Gannett Co. sent a letter Monday to shareholders defending its growth strategy and recommending they reject a newspaper company's t.....»»